FreeStyle Libre 3 CGM

The FreeStyle Libre 3 Continuous Glucose Monitoring (CGM) system is a medical device designed to help people with diabetes manage their blood sugar levels more effectively by providing real-time glucose readings and trends. Studies have consistently found that the FreeStyle Libre 3 offers high accuracy in both pediatric and adult populations, with point accuracy comparable to other widely used CGM systems. The advanced algorithm and improved sensor design contribute to its reliability over a 14- to 15-day wear period, making it a valuable tool for real-time glucose monitoring.

The device has been shown to improve glycemic control in individuals with type 2 diabetes who are using basal insulin plus SGLT2 inhibitors and/or GLP-1 agonists. In clinical trials, the FreeStyle Libre 3 demonstrated consistent performance across various metrics, including time in range and hypoglycemia detection. The system's accuracy is particularly notable for its factory-calibrated nature, which eliminates the need for frequent fingerstick calibrations.

While the FreeStyle Libre 3 has strong connections to improved glycemic outcomes and user convenience, it also integrates well with other diabetes management strategies, such as insulin therapy and lifestyle modifications. However, the evidence base is still evolving, and more long-term studies are needed to fully understand its impact on patient outcomes.

Sources

• Comparison of Point Accuracy Between Two Widely Used Continuous Glucose Monitoring Systems. (PMID:38189290)
• Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes. (PMID:32954812)
• Impact of real-time glucose monitoring using FreeStyle Libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and/or GLP-1 agonist: the FreeDM2 randomised controlled trial protocol. (PMID:40233956)
• Accuracy of a 15-day Factory-Calibrated Continuous Glucose Monitoring System With Improved Sensor Design. (PMID:40183340)
• A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems. (PMID:40198142)
• Performance of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes. (PMID:39902649)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._